NuGenerex Distributions Solutions, LLC
NuGenerex Distribution Solutions (NDS) integrates the acquisition of Veneto Holdings MSO network, a new pharmacy network, clinical diagnostic laboratories, a durable medical equipment company (DME-IQ) and a dedicated call center.
NuGenerex Distribution Solutions (NDS) integrates the acquisition of Veneto Holdings MSO network, a new pharmacy network, clinical diagnostic laboratories, a durable medical equipment company (DME-IQ) and a dedicated call center. NDS and the newly acquired assets have been organized with a focus on enhancing the doctor/patient relationship through a single point of access for “high quality” ancillary services and patient support.
NDS’ MSO currently operates in Arizona, Colorado, New Mexico, Oklahoma and Texas with growth plans that include geographic expansion to over 20 states, introduction of new products and services, and offering new physician modalities. The Company is also reviewing additional complementary acquisitions that could add significant revenue and earnings growth to NDS.
NDS also purchased assets of a network of ancillary services providers that include:
- Full-service, open-door retail pharmacies
- An in-network diagnostic blood laboratory
- A wholesale company
- A DME management company
- A dedicated call center focused on patient education and
NDS’s MSO subsidiary maintains management services contracts with these ancillary providers to manage billing and collections, insurance verification and adjudication, regulatory compliance and legal, credentialing, accounting, marketing and IT.
The combination of NDS’ MSO and recently acquired ancillary service providers allow patients to receive more comprehensive and easier access to healthcare while in parallel reducing the administrative burden on the ancillary health services providers allowing them to spend more time providing the highest quality of patient care.
In addition to geographic expansion, NDS is also expanding its pharmacy product offerings through a wholesale purchasing company that allows for easier identification of novel non-opioid treatments to use in existing physician networks with increased negotiation with manufacturers to allow for reduced cost of medications.
To complete the Generex vision of an integrated healthcare framework, Generex is working to acquire a revenue-generating company in the direct-to-patient pharmacy space with supporting IT services. Together with our MSO and pharmacy network, this acquisition will provide a powerful database of consumers and patients that represent a unique, qualified business development channels for drugs, DME, and medical devices. Furthermore, the database systems will support service offerings for chronic care and medication therapy management as well as patient support services through our dedicated healthcare call centers.